Drug intelligence / Profile preview

evans blue

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous
01

Overview

Evans blue is a synthetic azo dye with a very high affinity for serum albumin, making it useful as a physiological tracer and diagnostic agent. It is primarily used to estimate blood plasma volume, assess vascular and cellular membrane permeability, detect lymph nodes, and localize tumor lesions. Evans blue acts pharmacologically as a negative allosteric modulator of AMPA and kainate receptors, an inhibitor of vesicular glutamate transporters, and an antagonist at P2X-selective purinoceptors. It has also demonstrated dual antiviral effects against hepatitis B virus by inhibiting viral binding to host cells via NTCP and interfering with capsid assembly. Evans blue is non-toxic at diagnostic doses and can be administered intravenously; its strong binding to albumin allows for visualization in tissues using colorimetric or fluorescence-based methods[1][2][3][4][6].

Other names
evans blueazovan blueevan's blue
02

Targets

VGLUT (Vesicular glutamate transporter family)AMPAR (AMPA receptor)Kainate-type ionotropic glutamate receptor

Beyond the preview

Go deeper on evans blue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on evans blue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call